Publications
- What as the predictor factors for response to therapy with tocilizumab in real clinical practice? Experiences from national registry ATTRA2013 | First Faculty of Medicine
- New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis2023 | First Faculty of Medicine, Second Faculty of Medicine
- Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Cardiovascular risk in myositis patients compared with the general population2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study2023 | First Faculty of Medicine
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
- Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies2023 | First Faculty of Medicine
- Hsp90 Levels in Idiopathic Inflammatory Myopathies and Their Association With Muscle Involvement and Disease Activity: A Cross-Sectional and Longitudinal Study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Hsp90 as a Myokine: Its Association with Systemic Inflammation after Exercise Interventions in Patients with Myositis and Healthy Subjects2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
Loading network view...